Stručni rad

ANTIPSYCHOTICS AND THE QUALITY OF LIFE OF SCHIZOPHRENIC PATIENTS

Svjetlana Loga-Zec ; Institute of Pharmacology, Clinical Pharmacology and Toxicology, Medical Faculty, University of Sarajevo, Sarajevo, Bosnia and Herzegovina
Slobodan Loga ; Academy of Sciences and Arts of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina

Sažetak

Patients’ attitudes and values, their concept of illness and health as well as their previous experiences with medication may
significantly affect the subjective response to antipsychotics. Quality of Life (QOL) has holistic concept that includes consideration
of economic development, social vitality and environmental health. For most of the researches, QOL has an umbrella concept, which
covers all aspects of life and includes physical and mental health, family relations, friendship, employment, leisure activities, medical
treatment and quality of care, psychological and social benefit. In the domain of mental health, increasing the quality of treatment
can be demonstrated through improvements of QOL of those using the mental health services. When measuring QOL in patients
taking antipsychotics, it is important to acknowledge that a variety of factors may influence the QOL outcomes: these include side
effects and daily dosage of the antipsychotic, depressive and negative symptoms, duration of treatment, and subjective tolerability.

Ključne riječi

antipsychotics; schizophrenic patients; quality of life (QOL)

Hrčak ID:

76369

URI

https://hrcak.srce.hr/76369

Datum izdavanja:

8.12.2010.

Posjeta: 829 *